Clinical Trial Update: Injectable Bulking Agent Needle Guide [Phase 1]

View source ↗

Summary

A Phase 1 trial of an injectable bulking agent needle guide for urinary incontinence due to intrinsic sphincter deficiency has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrinsic Sphincter Deficiency
• Urinary Incontinence

Snippet

Sponsor: Carbon Medical Technologies | Conditions: Urinary Incontinence, Intrinsic Sphincter Deficiency | Phase 1 | Status: TERMINATED